Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Royal Prima TbkISX:PRIM +0.84%73 EV-to-OCF is 41.76 as of Aug. 29, 2026, which is 214% above its 10-year median of 13.32. GuruFocus rates ISX:PRIM with a GF Score™ of 73/100 and a GF Value™ of Rp77.94 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 685 Healthcare Providers & Services companies, PT Royal Prima Tbk ranks worse than 90.36% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, PT Royal Prima Tbk's Enterprise Value is Rp384,640 Mil.
PT Royal Prima Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was Rp9,212 Mil. Therefore, PT Royal Prima Tbk's EV-to-OCF for today is 41.76.
The historical rank and industry rank for PT Royal Prima Tbk's EV-to-OCF or its related term are showing as below:
ISX:PRIM'
s EV-to-OCF Range Over the Past 10 Years
Min: -59.75 Med: 13.32 Max: 466.17
Current: 40.66
During the past 12 years, the highest EV-to-OCF of PT Royal Prima Tbk was 466.17. The lowest was -59.75. And the median was 13.32.
ISX:PRIM's EV-to-OCF is ranked worse than 90.36% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 8.93
vs ISX:PRIM: 40.66
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Royal Prima Tbk (ISX:PRIM) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PT Royal Prima Tbk's PE Ratio (TTM) for today is calculated as:
PT Royal Prima Tbk's share price for today is Rp120.00.
PT Royal Prima Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-5.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
PT Royal Prima Tbk EV-to-OCF Related Terms
PT Royal Prima Tbk EV-to-OCF Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, PT Royal Prima Tbk's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Royal Prima Tbk EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Royal Prima Tbk's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where PT Royal Prima Tbk's EV-to-OCF falls into.
PT Royal Prima Tbk's current Enterprise Value is Rp384,640 Mil.
PT Royal Prima Tbk's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp9,212 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Royal Prima Tbk (ISX:PRIM) has a EV-to-OCF of 41.76 as of Aug. 29, 2026. This is 214% above median its historical median of 13.32. According to the industry distribution chart, PT Royal Prima Tbk ranks #619 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 90.4%.
Is PT Royal Prima Tbk's EV-to-OCF too high?
PT Royal Prima Tbk's current EV-to-OCF of 41.76 is 214% above median its 10-year median of 13.32. The Healthcare Providers & Services industry median EV-to-OCF is 8.93. PT Royal Prima Tbk's value of 41.76 is 367.6% above this industry median. Based on the distribution chart, PT Royal Prima Tbk ranks #619 out of 685 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Royal Prima Tbk has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Royal Prima Tbk ranks #619 out of 685 companies for EV-to-OCF. This places PT Royal Prima Tbk in the lower half of its industry. The industry median EV-to-OCF is 8.93. PT Royal Prima Tbk's value of 41.76 is 367.6% above this benchmark. While the company's 10-year median is 13.32 vs. the industry median of 8.93, PT Royal Prima Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.93, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Royal Prima Tbk's current EV-to-OCF of 41.76 is 367.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Royal Prima Tbk's current EV-to-OCF is 41.76, which is 214% above median its own 10-year median of 13.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Significantly Overvalued. The stock's GF Value™ is Rp77.94, compared to a current price of Rp120.00 — trading 54% above its estimated fair value. The current EV-to-OCF is 41.76, which is 214% above median its 10-year median of 13.32 and 367.6% above the Healthcare Providers & Services industry median of 8.93. PT Royal Prima Tbk's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current EV-to-OCF is 41.76 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp120.00 is trading 54% above its estimated GF Value™ of Rp77.94.
GuruFocus considers PT Royal Prima Tbk to be Significantly Overvalued.
Key valuation signals for ISX:PRIM:
EV-to-OCF: 41.76 (214% above median its 10-year median of 13.32)
GF Value™: Rp77.94 vs. price of Rp120.00 (54% above fair value)
Industry Position: 367.6% above the Healthcare Providers & Services median (#619 of 685)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
73GF Score
Get the complete analysis for ISX:PRIM
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
